森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/28 | 1,928 | 1,943 | 1,928 | 1,943 | +13 | +0.7% | 2,400 |
| 2022/03/25 | 1,925 | 1,930 | 1,924 | 1,930 | +5 | +0.3% | 1,200 |
| 2022/03/24 | 1,925 | 1,925 | 1,916 | 1,925 | -1 | -0.1% | 1,300 |
| 2022/03/23 | 1,926 | 1,926 | 1,925 | 1,926 | ±0 | ±0% | 1,600 |
| 2022/03/22 | 1,930 | 1,931 | 1,926 | 1,926 | -1 | -0.1% | 900 |
| 2022/03/18 | 1,914 | 1,927 | 1,914 | 1,927 | +13 | +0.7% | 500 |
| 2022/03/17 | 1,927 | 1,936 | 1,914 | 1,914 | -13 | -0.7% | 2,100 |
| 2022/03/16 | 1,922 | 1,928 | 1,922 | 1,927 | +2 | +0.1% | 800 |
| 2022/03/15 | 1,920 | 1,925 | 1,920 | 1,925 | +3 | +0.2% | 1,200 |
| 2022/03/14 | 1,923 | 1,923 | 1,914 | 1,922 | - | - | 400 |
| 2022/03/11 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/03/10 | 1,912 | 1,913 | 1,912 | 1,913 | +3 | +0.2% | 300 |
| 2022/03/09 | 1,913 | 1,914 | 1,904 | 1,910 | -1 | -0.1% | 2,400 |
| 2022/03/08 | 1,924 | 1,924 | 1,911 | 1,911 | -13 | -0.7% | 1,500 |
| 2022/03/07 | 1,914 | 1,924 | 1,914 | 1,924 | +4 | +0.2% | 700 |
| 2022/03/04 | 1,915 | 1,922 | 1,915 | 1,920 | -4 | -0.2% | 400 |
| 2022/03/03 | 1,915 | 1,924 | 1,910 | 1,924 | +9 | +0.5% | 1,200 |
| 2022/03/02 | 1,914 | 1,915 | 1,907 | 1,915 | +1 | +0.1% | 1,600 |
| 2022/03/01 | 1,907 | 1,914 | 1,907 | 1,914 | +1 | +0.1% | 400 |
| 2022/02/28 | 1,914 | 1,914 | 1,903 | 1,913 | -1 | -0.1% | 1,300 |
| 2022/02/25 | 1,914 | 1,914 | 1,911 | 1,914 | +11 | +0.6% | 900 |
| 2022/02/24 | 1,903 | 1,912 | 1,901 | 1,903 | -2 | -0.1% | 800 |
| 2022/02/22 | 1,906 | 1,910 | 1,905 | 1,905 | -1 | -0.1% | 900 |
| 2022/02/21 | 1,910 | 1,920 | 1,906 | 1,906 | -9 | -0.5% | 1,000 |
| 2022/02/18 | 1,912 | 1,916 | 1,910 | 1,915 | +4 | +0.2% | 800 |
| 2022/02/17 | 1,911 | 1,911 | 1,905 | 1,911 | ±0 | ±0% | 700 |
| 2022/02/16 | 1,910 | 1,911 | 1,910 | 1,911 | +3 | +0.2% | 700 |
| 2022/02/15 | 1,907 | 1,908 | 1,903 | 1,908 | +2 | +0.1% | 1,000 |
| 2022/02/14 | 1,900 | 1,906 | 1,900 | 1,906 | +6 | +0.3% | 400 |
| 2022/02/10 | 1,897 | 1,905 | 1,897 | 1,900 | -1 | -0.1% | 500 |
| 2022/02/09 | 1,904 | 1,906 | 1,895 | 1,901 | -2 | -0.1% | 2,800 |
| 2022/02/08 | 1,902 | 1,903 | 1,896 | 1,903 | +8 | +0.4% | 400 |
| 2022/02/07 | 1,901 | 1,903 | 1,895 | 1,895 | -4 | -0.2% | 800 |
| 2022/02/04 | 1,899 | 1,900 | 1,890 | 1,899 | ±0 | ±0% | 1,200 |
| 2022/02/03 | 1,898 | 1,900 | 1,891 | 1,899 | +1 | +0.1% | 1,200 |
| 2022/02/02 | 1,897 | 1,898 | 1,897 | 1,898 | +3 | +0.2% | 200 |
| 2022/02/01 | 1,896 | 1,898 | 1,895 | 1,895 | ±0 | ±0% | 1,000 |
| 2022/01/31 | 1,884 | 1,898 | 1,884 | 1,895 | +11 | +0.6% | 700 |
| 2022/01/28 | 1,880 | 1,884 | 1,880 | 1,884 | -1 | -0.1% | 500 |
| 2022/01/27 | 1,896 | 1,899 | 1,885 | 1,885 | -15 | -0.8% | 1,500 |
| 2022/01/26 | 1,900 | 1,900 | 1,899 | 1,900 | -1 | -0.1% | 500 |
| 2022/01/25 | 1,899 | 1,901 | 1,899 | 1,901 | +7 | +0.4% | 1,100 |
| 2022/01/24 | 1,888 | 1,902 | 1,870 | 1,894 | +6 | +0.3% | 5,200 |
| 2022/01/21 | 1,892 | 1,898 | 1,888 | 1,888 | -12 | -0.6% | 1,200 |
| 2022/01/20 | 1,900 | 1,900 | 1,892 | 1,900 | +10 | +0.5% | 500 |
| 2022/01/19 | 1,900 | 1,902 | 1,884 | 1,890 | -8 | -0.4% | 1,900 |
| 2022/01/18 | 1,885 | 1,902 | 1,885 | 1,898 | +14 | +0.7% | 500 |
| 2022/01/17 | 1,880 | 1,894 | 1,880 | 1,884 | -19 | -1% | 4,400 |
| 2022/01/14 | 1,903 | 1,903 | 1,900 | 1,903 | ±0 | ±0% | 500 |
| 2022/01/13 | 1,902 | 1,903 | 1,902 | 1,903 | +3 | +0.2% | 200 |
751～
800
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 208,200円 | +2.4% | +10.4% | 2.64% | 12.17倍 | 0.68倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＮＡＮＯ | 13,600円 | -20.0% | - | 0.00% | - | 3.15倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| カイオム | 13,500円 | +92.3% | - | 0.00% | - | 4.79倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| サイフューズ | 101,400円 | +459.3% | - | 0.00% | - | 3.33倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| ラクオリア | 36,200円 | +25.1% | - | 0.00% | - | 1.43倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
